¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Amino Acid Transport Systems, Neutral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • phytanic acid storage disease
    ÇÇź»êÃàÀûº´
  • picramic acid
    ÇÇÅ©¶÷»ê
  • pantoic acid
    ÆÇÅä»ê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • propanoic acid
    ÇÁ·ÎÆÇ»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
  • pyruvic acid
    ÇÇ·çºê»ê
  • periodic acid-Schiff stain
    PAS¿°»ö
  • palmitic acid
    ÆÈ¹ÌÆ®»ê
  • retinoic acid
    ·¹Æ¼³ë»ê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, RNA
  • saccharic acid
    »çÄ«¸°»ê
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • taurocholic acid
    Ÿ¿ì·ÎÄÝ»ê
  • teichoic acid
    Å×ÀÌÄÚ»ê
  • teichuronic acid
    Å×ÀÌÅ¥·Ð»ê
  • tricarboxylic acid
    »ïÄ«¸£º¹½Ç»ê
  • trichloroacetic acid
    »ï¿°È­¾Æ¼¼Æ®»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • uridine diphosphate glucuronic acid
    ÀÌÀλêÀ¯¸®µò±Û·çÄí·Ð»ê
  • urocanic acid
    À¯·ÎÄ«´Ñ»ê
  • uronic acid
    À¯·Ð»ê
  • ursodeoxycholic acid
    ¿ì¸£¼Òµð¿Á½ÃÄݸ°»ê
  • volatile acid
    Èֹ߼º»ê
  • boric acid ointment
    ºØ»ê¿¬°í
  • carbolic acid gangrene
    ¼®Åº»ê±«Àú
  • citric acid cycle
    ±¸¿¬»êȸ·Î, ½ÃÆ®¸£»êȸ·Î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • homogentisic acid
    È£¸ð°ÕƼ½Å»ê, Homogentisin »ê
  • homogentisic acid
    È£¸ð°ÕƼ½Å»ê
  • homogentisic acid oxidase
    È£¸ð°ÕƼ½Å»ê »êÈ­È¿¼Ò(¡­ß«ß«ûùý£áÈ).
  • homogentisic acid oxidase
    È£¸ð°ÕƼ½Å»ê»êÈ­È¿¼Ò
  • homopilopic acid
    È£¸ðÇÊ·ÎÇÁ»ê.
  • homovanillic acid
    È£¸ð¹Ù´Ò¸°»ê
  • hyaluronic acid
    È÷¾Ë·ç·Ð»ê(¡­ß«).
  • hyaluronic acid
    ÇÏÀ̾ËÀ¯·Ð»ê(¡­ß«).
  • hybridization, nucleic acid
    ÇÙ»êºÎÇÕ¹ý(ݬùêÛö)
  • hydrochloric acid
    ¿°»ê
  • hydrochloric acid
    ¿°»ê(ç¤ß«)
  • hydrochloric acid milk
    ¿°»êÀ¯(¡­êá).
  • hydrocyanic acid
    È÷µå·Î½Ã¾È»ê(¡­ß«).
  • hydroferricyanic acid
    Æä¸®½Ã¾È»ê.
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê(Ý×ûù â©áÈß«)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • aminohippuric acid
    ¾Æ¹Ì³ë ¸¶´¢»ê
  • anaphylaxis,arachidonic acid metabolitesin
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú(¡­ß« ÓÛÞóÚªòõ)
  • anthranilic acid
    ¾ÈÆ®¶ó´Ò»ê.
  • apoascorbic acid
    ¾ÆÆ÷¾Æ½ºÄÚ¸£ºó»ê.
  • arachidonic acid
    ¾Æ¶ó۵·»ê
  • arachidonic acid
    ¾Æ¶ó۵·»ê(¡­ß«)
  • arachidonic acid metabolism
    ¾Æ¶ó۵·»ê´ë»ç
  • arachidonic acid metabolites
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú(¡­ÓÛÞóÚªòõ)
  • arginine-glycine-aspartic acid
    Arginine-glycine-aspartic acid
  • arsenic acid
    ºñ»ê(Ý÷ß«).
  • arsenoacetic acid
    ¾Æ¸£¼¼³ë¾Æ¼¼Æ®»ê.
  • arsenous acid
    ¾Æºñ»ê(ä¬Ý÷ß«).
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê.
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê(¡­ß«)
  • ascorbic acid = vitamin C
    ¾Æ½ºÄÚ¸£ºó»ê = ºñŸ¹Î C
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • concerted acid-base catalysis
    Çùµ¿ »ê¿°±â Ã˸Å(úðÔÒß«ç¤ÐñõºØÚ)
  • conjugate acid-base pair
    ¦ÁöÀº »ê¿°±â½Ö(ß«ç¤Ðñäª)
  • cortoic acid
    ÄÚ¸£Æ¼¼Ö»ê(ß«)
  • cyclic adenylic acid °í¸® ¾Æµ¥´Ñ»ê(ß«)
    "(ÔÒ)(ÔÒ) adenosine-3',5'-cyclic monophosphate,"
  • cysteic acid
    ½Ã½ºÅ×ÀÎ »ê(ß«)
  • cytidylic acid
    »çÀÌÆ¼µò »ê(ß«)
  • acid dihydrouridine.
    dalton
  • dehydroascorbic acid
    Å»¼ö¼Ò(÷­â©áÈ)¾Æ½ºÄÚ¸£ºó»ê(ß«)
  • deoxyadenylic acid
    µ¥¿Á½Ã¾Æµ¥´Ò»ê(ß«)
  • deoxycholic acid
    µ¥¿Á½ÃÄÝ»ê(ß«)
  • deoxycytidylic acid
    µ¥¿Á½Ã»çÀÌÆ¼µô»ê(ß«)
  • deoxyguanylic acid
    µ¥¿Á½Ã±¸¾Æ´Ò»ê(ß«)
  • deoxyribonucleic acid
    µ¥¿Á½Ã¶óÀ̺¸ÇÙ»ê(ß«)
  • deoxyribose nucleic acid
    "µ¥¿Á½Ã¶óÀ̺¸½º ÇÙ»ê(ú·ß«), (ÔÒ) deoxyribonucleic acid"
  • deoxythymidylic acid
    "µ¥¿Á½ÃŸÀ̵̹ô»ê(ß«), (ÔÒ) thymidylic acid"
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
AAMSI American Association for Medical Systems and Informatics
ACCESS Ambulatory Care Clinic Effectiveness Systems Study; automated cervical cell screening system
COSMIS Computer System for Medical Information Systems
COTH Council of Teaching Hospitals and Health Systems
DBMS data base management systems
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
D(-)AP5 D(-)-2-amino-5-phosphonopentanoic acid
D(-)APV D(-)-2-amino-5-phosphonovaleric acid
D(-)AP5 D(-)2-amino-5-phosphonovaleric acid
D-AAO D-Amino acid oxidase
DAO D-Amino acid oxidase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • phosphoric acid
    Àλê
    ¿À»êÈ­ÀÎ PO°¡ ¼öÈ­ÇÏ¿© »ý±â´Â ÀÏ·ÃÀÇ »ê mPO, nHOÀÇ ÃÑĪ. ¸ÞŸ Àλê, ÇÇ·Î Àλê, ¿À¸£Åä Àλê, »ïÀλê, »çÀÎ»ê µîÀÌ ÀÖ°í, ÀÌ ¹Û¿¡ ¸ÞŸ ÀλêÀÇ ÁßÇÕ¿¡ ÀÇÇØ¼­ »ý±â´Â Æú¸® ¸ÞŸ ÀλêÀÇ °è¿­µµ ÀÖÀ¸³ª, ÀϹÝÀûÀ¸·Î´Â ¿À¸£Åä ÀλêÀ» °¡¸®Å²´Ù. ÀλêÀÇ ¼ºÁúÀº ¹«»ö, ¹«ÃëÀÇ Á¡¼ºµµ°¡ Å« ¾×üÀ̸ç, ³óµµ°¡ ³ô¾ÆÁö¸é °áÁ¤È­Çϱ⠽±´Ù. ³ì´ÂÁ¡ 42.35 ¡É, ºñÁß 1.834ÀÌ´Ù. Á¶ÇؼºÀÌ ÀÖ°í, 100 gÀÇ ¹°¿¡ 20 ¡É¿¡¼­ 542 g ³ì´Â´Ù. ºñÈֹ߼ºÀÌ¸ç °¡¿­Çϸé ÇÇ·Î ÀλêÀ̳ª Æú¸® ÀλêÀÌ µÇ°í, ´õ °¡¿­ÇÏ¸é ¸ÞŸ ÀλêÀÌ µÈ´Ù. ¾ËÄڿÿ¡µµ ³ì´Â´Ù. ±Ý¼Ó ¹× ±× »êÈ­¹°À» °Ý·ÄÇÏ°Ô Ä§½ÄÇÑ´Ù. ÀϹÝÀûÀ¸·Î »ýü ³»¿¡¼­´Â Àλê ÇüÅ·Î, »ý¹°°è¿¡¼­´Â Àλ꿰 ¶Ç´Â ÀÎ»ê ¿¡½ºÅ׸£ÀÇ ÇüÅ·ΠÇÙ»ê, ÀÎ ´Ü¹éÁú, ÀÎ ÁöÁú µî »ýüÀÇ ÁÖ¿ä ±¸¼º ¼ººÐÀ» Çü¼ºÇÑ´Ù. °í¿¡³ÊÁö ÀÎ»ê °áÇÕÀ» ¸¸µé¾î ¿¡³ÊÁö ¿î¹ÝüÀÇ ±¸½ÇÀ» ÇÏ´Â µî, »ýÈ­Çлó Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù.
  • polyacrylic acid
    Æú¸® ¾ÆÅ©¸±¸¯ »ê
  • polyenic acid
    Æú¸®¿£»ê
    ź¼ÒüÀÇ ÀÌÁß °áÇÕÀÌ µÎ°³ ÀÌ»ó Á¸ÀçÇÏ´Â Áö¹æ»ê.
  • polyunsaturate fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
    ¿À¸£Åä ÀλêÀ» 200-300µµ·Î ¿À·¡ °¡¿­ÇÒ ¶§ »ý±â´Â Å« °áÁ¤.
  • pyruvic acid
    ÆÄÀÌ·çºó»ê, Ãʼº Æ÷µµ»ê
    ź¼öÈ­¹° ´ë»çÀÇ Áß°£ ¹°Áú. ¶ó½Ã¹Ì »êÀ̳ª ÁÖ¼®»êÀÇ °Ç·ù¿¡ ÀÇÇØ »ý¼ºµÉ ¼ö ÀÖ´Ù.
  • quinaldinic acid
    Ű³¯µò»ê
  • quinolinic acid
    Ű³î¸°»ê
    ¹«»öÀÇ ÁÖ»ó °áÁ¾À¸·Î, Ű³î¸°ÀÇ »êÈ­ »ý¼º¹°.
  • ribonucleic acid
    ¸®º¸ ÇÙ»ê
    È¿¸ð¿¡¼­ óÀ½À¸·Î ºÐ¸®µÈ ÇÙ»êÀ¸·Î ³ªÁß¿¡´Â ¸ðµç »ì¾ÆÀÖ´Â ¼¼Æ÷¿¡¼­µµ ¹ß°ßµÇ¾ú´Ù. °¡¼öºÐÇØÇÏ¸é ¾Æµ¥´Ñ, ±¸¾Æ´Ñ, »çÀÌÅä½Å, ¿ì¶ó½Ç, ¶ûº¸½º, ÀλêÀÌ »ý±ä´Ù. RNA¶ó ¾à±âÇÑ´Ù.
  • saccharic acid
    »çÄ«¸°»ê, ´ç»ê, »èÄ«¸°»ê
    1. ÀÌ¿°±â»ê. COOH,
  • salicylic acid test
    »ì¸®½Ç»ê ½ÃÇè
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê
  • serum bile acid
    Ç÷û ´ãÁó»ê
    ¹Ì·® Á¸ÀçÇÑ´Ù.
  • serum free fatty acid
    Ç÷û À¯¸® Áö¹æ»ê Á¤·®
    Á¤»óÄ¡´Â Á¶±â °øº¹ ½Ã 200-600¥ìEq/l·Î »ý¸®Àû º¯µ¿ÀÌ Å©´Ù.
  • serum uric acid
    Ç÷û ´¢»ê
    Åëdz, ½ÅºÎÀü, ¹éÇ÷º´ µîÀ¸·Î °í´¢»êÁõÀÌ »ý±ä´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
amino alcohols Compounds possessing both a hydroxyl (-oh) and an amino group (-nh2).
(12 Dec 1998)
amino group <biochemistry> An -NH2 group. Organic compounds which have this group are called amines.
(09 Oct 1997)
amino sugar <biochemistry> Monosaccharide in which an OH group is replaced with an amino group, often acetylated. Common examples are D galactosamine, D glucosamine, neuraminic acid, muramic acid. Amino sugars are important constituents of bacterial cell walls, some antibiotics, blood group substances, milk oligosaccharides and chitin.
(18 Nov 1997)
amino sugars Sugar's in which a hydroxyl group has been replaced with an amino group; e.g., d-glucosamine.
(05 Mar 2000)
amino-terminal <biochemistry> The end of a protein or polypeptide chain with the unattached amino group or the aminoacyl residue containing it.
Each amino acid in the chain has an amino group on one side, which is attached to the carboxyl group (COOH group) of the previous amino acid, and a carboxyl group on the other side (which is attached to the amino group of the next amino acid). The other end of the polypeptide chain is called the carboxyl terminal.
Synonym: NH2-terminal.
(14 Aug 2000)
amino-terminal residue <biochemistry> The only amino acid residue in a polypeptide chain that has a free alpha-amino group, it defines the amino terminus of the polypeptide.
(09 Oct 1997)
RNA, transfer, amino acyl Intermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl trna synthetase. They are key compounds in the genetic translation process.
(12 Dec 1998)
c-Jun amino-terminal kinase <enzyme> A stress-activated protein kinase; 46-kD kinase that phosphorylates ser(63) and ser(73) of c-jun; similar to yeast hog1 kinase; amino acid sequence given in second source; genbank l23118
Registry number: EC 2.7.10.-
Synonym: jn kinase, jnk1 protein kinase, jnk-46, jnk1 protein, jun-nh2-terminal kinase, stress-activated protein kinase 1, sap kinase-1, sapk1, p46 sap kinase, c-jun kinase-1
(26 Jun 1999)
N-(5'-phosphoribosylformimino)-5-amino-1-(5''-phosphoribosyl)-4-imidazolecarboxamide isomerase <enzyme> Has beta/alpha-barrel fold structure; involved in biosynthesis of histidine
Registry number: EC 5.3.1.16
Synonym: hisa gene product, pfacr isomerase, phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase
(26 Jun 1999)
succinylalanyl-alanyl-prolyl-phenylalanyl-7-amino-4-methylcoumarin hydrolase <enzyme> Enzyme may be involved in attainment of transformed state
Registry number: EC 3.4.24.-
Synonym: suc-ala-ala-pro-phe-amc hydrolase, saapp-amc-hydrolase
(26 Jun 1999)
essential amino acids Alpha-amino acids nutritionally required by an organism and which must be supplied in its diet (i.e., cannot be synthesised by the organism) either as free amino acid or in proteins.
(05 Mar 2000)
excitatory amino acids Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear.
(12 Dec 1998)
2-amino-2-deoxy-D-galactose <chemical> Chemical name: D-Galactose, 2-amino-2-deoxy-
(12 Dec 1998)
2-amino-5-phosphonovalerate <chemical> A potent and specific antagonist of nmda receptors (receptors, nmda) in the d-enantiomeric form. The l form is inactive at nmda receptors but may affect the ap4 (2-amino-4-phosphonobutyrate; apb) excitatory amino acid receptors.
Pharmacological action: excitatory amino acid antagonists.
Chemical name: Norvaline, 5-phosphono-
(12 Dec 1998)
(3-(arginyl)amino-4-(4-nitrophenyl)butyryl)-leucyl-prolyl-threonine Pharmacological action: neurotransmitters
Synonym: 2-afb(p-no2)-proctolin, (afb(p-no2)(2))-proctolin
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á